Predicting the functional consequences of cancer-associated amino acid substitutions.
about
Practical aspects of NGS-based pathways analysis for personalized cancer science and medicineGenome Sequence Variability Predicts Drug Precautions and Withdrawals from the MarketCOSMIC: exploring the world's knowledge of somatic mutations in human cancerTargeted and genomewide NGS data disqualify mutations in MYO1A, the "DFNA48 gene", as a cause of deafness.Determining effects of non-synonymous SNPs on protein-protein interactions using supervised and semi-supervised learning.Body-hypomethylated human genes harbor extensive intragenic transcriptional activity and are prone to cancer-associated dysregulationDOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes.Gene-specific function prediction for non-synonymous mutations in monogenic diabetes genes.Germline mutations in MAP3K6 are associated with familial gastric cancerRanking non-synonymous single nucleotide polymorphisms based on disease conceptsVariation Interpretation Predictors: Principles, Types, Performance, and Choice.Use of long term molecular dynamics simulation in predicting cancer associated SNPs.Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studiesComputational methods and resources for the interpretation of genomic variants in cancerWhole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genesTemple-Baraitser Syndrome and Zimmermann-Laband Syndrome: one clinical entity?Inferring Crohn's disease association from exome sequences by integrating biological knowledge.GTB - an online genome tolerance browserDiagnosis implications of the whole genome sequencing in a large Lebanese family with hyaline fibromatosis syndrome.Dynamic changes of driver genes' mutations across clinical stages in nine cancer typesAdvances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomesEstablishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.Decreased level of RASSF6 in sporadic colorectal cancer and its anti-tumor effects both in vitro and in vivoChallenges and disparities in the application of personalized genomic medicine to populations with African ancestry.iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes.Interaction-based discovery of functionally important genes in cancers.Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicingDriverDB: an exome sequencing database for cancer driver gene identification.Identifying Highly Penetrant Disease Causal Mutations Using Next Generation Sequencing: Guide to Whole Process.Targeting tumor suppressor genes for cancer therapy.The genetic landscape of endometrial clear cell carcinomas.Mutations in Cancer Cause Gain of Cysteine, Histidine, and Tryptophan at the Expense of a Net Loss of Arginine on the Proteome Level.Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases.Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.Unsupervised detection of cancer driver mutations with parsimony-guided learning.An integrative approach to predicting the functional effects of non-coding and coding sequence variation.Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1.InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP GuidelinesSix Germline Genetic Variations Impair the Translesion Synthesis Activity of Human DNA Polymerase κ.Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.
P2860
Q26748603-3343EB45-FE9F-4BF3-9CCA-6F944566C875Q28554426-88E1C617-5919-4114-8576-8208F72153E0Q29615725-1D5BAD4A-62BD-4A90-9B22-094E89C937F0Q30774855-7CEDEE7B-7E58-46BB-A438-157041D7DAE6Q33552939-71852CDB-DF89-4B3D-B190-89437ADC54BBQ33635817-96B05749-5F52-4999-B023-8E86934D5C17Q33858472-E4A8A164-3B51-41D9-98DA-096FFE8BDE52Q34066401-0A7A3C7B-2B38-4958-8F47-EB30ABEFF4F1Q34394597-07F41083-E3FC-4D80-8B66-D23C127566F0Q34427162-E1368E92-2468-4626-9738-BB916FC8FC78Q34518645-1A949E37-8DFF-4F6E-A458-CC0965E5FE00Q35144962-99E5AC5E-FF90-4781-9E24-F2B3B32CEB07Q35221430-46306AF6-42B7-43DD-9DB6-2FE2706C0F23Q35674603-BEDD2EA0-13BE-445C-9D44-E020628F3D10Q35706511-5DCBD288-4931-404A-B9F0-9D3187B7F8A0Q36047304-6F165BBC-1830-406B-BC83-412BB5271410Q36106337-B6E3D07F-B998-4907-9621-F7CB6FF18C1AQ36243048-F84ED3B1-4643-4306-A0A3-71C89DAB878BQ36254263-4DDE4CD2-C2A2-407F-932B-6F1E9CA6BBAAQ37094931-2E291513-A015-4FF1-8DD1-A779A5F10C1BQ37096363-189BD25E-253E-44E6-B8AF-713D283118EEQ37136357-B49D3FC0-9D27-40EE-B420-1440C3110D76Q37190181-C4805D3F-8110-4A07-AACC-8664D379DE32Q37336084-7FA01CAF-60F4-47FA-92DE-23D0D5222162Q37529618-127BFBD0-052D-4B7D-B87F-27A804C16557Q37574182-26653D46-6356-4129-9B06-31E2280EFAE0Q37587671-0F16161E-7023-4B32-9914-D03A97096A80Q37661903-71E32A71-1AF2-46BC-AB71-CFEE281864BAQ38536630-927477BE-CA21-494F-BB55-73DC4C849E76Q38601568-8925411E-4871-4998-8D15-A3111A88B799Q38674086-828A6D49-89CA-4A2D-B246-9D2EC15C9257Q38696897-41833D83-BB64-44EB-B8CF-78D9160B1666Q38700667-CCC99B06-36F9-4C5B-9910-29B7D9528D9AQ38830136-8E3DD372-25EB-4A16-A732-5CF27D7ADD07Q39400856-B1B2EA98-27D6-4BD6-BE99-C6A1D1C0F0DFQ40518007-BABD2A6D-728F-4243-9D17-ECC6281A127AQ41044192-98E99A3D-5F65-4449-AE7F-905B46C32D9EQ41830006-3DD61C17-C0C8-4888-9D2D-517B7667E252Q42365650-D4A77D7B-47F6-4626-945A-101090B5A0FBQ42473382-64E4C864-4AE2-40B7-9166-ACF7F30487E2
P2860
Predicting the functional consequences of cancer-associated amino acid substitutions.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Predicting the functional consequences of cancer-associated amino acid substitutions.
@ast
Predicting the functional consequences of cancer-associated amino acid substitutions.
@en
Predicting the functional consequences of cancer-associated amino acid substitutions.
@nl
type
label
Predicting the functional consequences of cancer-associated amino acid substitutions.
@ast
Predicting the functional consequences of cancer-associated amino acid substitutions.
@en
Predicting the functional consequences of cancer-associated amino acid substitutions.
@nl
prefLabel
Predicting the functional consequences of cancer-associated amino acid substitutions.
@ast
Predicting the functional consequences of cancer-associated amino acid substitutions.
@en
Predicting the functional consequences of cancer-associated amino acid substitutions.
@nl
P2860
P50
P356
P1433
P1476
Predicting the functional consequences of cancer-associated amino acid substitutions.
@en
P2093
Hashem A Shihab
Ian N M Day
P2860
P304
P356
10.1093/BIOINFORMATICS/BTT182
P407
P577
2013-04-25T00:00:00Z